Ravagalimab
Product Specifications
CAS Number
2050816-56-1
Target
TNF
Related Pathways
Apoptosis
Purity
0.995
Bioactivity
Ravagalimab (ABBV-323) is a CD40 antagonist monoclonal antibody with an EC50 of 3.7 nM. Ravagalimab is being investigated for the treatment of inflammatory diseases such as Crohn’s disease and Sjögren’s syndrome (SS) . Research focuses on evaluating its pharmacological activity, efficacy, and safety in patients with primary Sjögren’s syndrome (pSS), highlighting its role in immune modulation.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Cyclic (adenosine- (2' −> 5') - monophosphorothioate- guanosine- (3' −> 5') - monophosphorothioate), isomer 2 (c[A (2',5') pS-G (3',5') pS] / 3'2'-cGAMPSS / 3',5'-2',5'-cGAMPSS), sodium salt](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
C 247-001 0.1 µmol ~ 71 µg
Cyclic (adenosine- (2' −> 5') - monophosphorothioate- guanosine- (3' −> 5') - monophosphorothioate), isomer 2 (c[A (2',5') pS-G (3',5') pS] / 3'2'-cGAMPSS / 3',5'-2',5'-cGAMPSS), sodium salt
Sign In for Pricing
View Details 
351091-01 50 µg
ARL9, Recombinant, Human, aa1-123, His-Tag (ADP-ribosylation factor-like 9)
Sign In for Pricing
View Details 351091-02 250 µg
ARL9, Recombinant, Human, aa1-123, His-Tag (ADP-ribosylation factor-like 9)
Sign In for Pricing
View Details